🇺🇸 FDA
Pipeline program

Rebamipide

C03700-003

Approved small_molecule completed

Quick answer

Rebamipide for Stomach Ulcer is a Approved program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
Otsuka Beijing Research Institute
Indication
Stomach Ulcer
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials